Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease

A. L. Mina Bergem; A. Burns; S. Eriksson; S. Finkel; S. Gauthier; R. Levy; L. Mallery; B. Reisberg; L. Schneider; R. Billington

doi:10.1017/S1041610296002694

Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease

A. L. Mina Bergem, A. Burns, S. Eriksson, S. Finkel, S. Gauthier, R. Levy, L. Mallery, B. Reisberg, L. Schneider, R. Billington

Medicine

Medicine

Résultat de recherche: Article › examen par les pairs

Langue d'origine	English
Pages (de-à)	335-342
Nombre de pages	8
Journal	International Psychogeriatrics
Volume	8
Numéro de publication	2
DOI	https://doi.org/10.1017/S1041610296002694
Statut de publication	Published - 1996

ASJC Scopus Subject Areas

Clinical Psychology
Gerontology
Geriatrics and Gerontology
Psychiatry and Mental health

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1017/S1041610296002694

Autres fichiers et liens

Citer

Mina Bergem, A. L., Burns, A., Eriksson, S., Finkel, S., Gauthier, S., Levy, R., Mallery, L., Reisberg, B., Schneider, L., & Billington, R. (1996). Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease. International Psychogeriatrics, 8(2), 335-342. https://doi.org/10.1017/S1041610296002694

Mina Bergem, AL, Burns, A, Eriksson, S, Finkel, S, Gauthier, S, Levy, R, Mallery, L, Reisberg, B, Schneider, L & Billington, R 1996, 'Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease', International Psychogeriatrics, vol. 8, n° 2, pp. 335-342. https://doi.org/10.1017/S1041610296002694

@article{67bef1161bbe44ecaec8ebf09cd5a262,

title = "Round table discussion: The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease",

author = "{Mina Bergem}, {A. L.} and A. Burns and S. Eriksson and S. Finkel and S. Gauthier and R. Levy and L. Mallery and B. Reisberg and L. Schneider and R. Billington",

year = "1996",

doi = "10.1017/S1041610296002694",

language = "English",

volume = "8",

pages = "335--342",

journal = "International Psychogeriatrics",

issn = "1041-6102",

publisher = "Cambridge University Press",

number = "2",

}

TY - JOUR

T1 - Round table discussion

T2 - The clinician's view on outcome methodologies for pharmacologic trials in mild, moderate, and severe Alzheimer's disease

AU - Mina Bergem, A. L.

AU - Burns, A.

AU - Eriksson, S.

AU - Finkel, S.

AU - Gauthier, S.

AU - Levy, R.

AU - Mallery, L.

AU - Reisberg, B.

AU - Schneider, L.

AU - Billington, R.

PY - 1996

Y1 - 1996

UR - http://www.scopus.com/inward/record.url?scp=0030465569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030465569&partnerID=8YFLogxK

U2 - 10.1017/S1041610296002694

DO - 10.1017/S1041610296002694

M3 - Article

AN - SCOPUS:0030465569

SN - 1041-6102

VL - 8

SP - 335

EP - 342

JO - International Psychogeriatrics

JF - International Psychogeriatrics

IS - 2

ER -